The global Breast Lesion Localization Methods market size is anticipated to reach around USD 2.3 bn by 2026, growing with 14.0% of CAGR during the forecast period 2018 to 2026.
Rising numeral of government and non-government repayment policies for the breast cancer diagnostics, biopsy, inspection, and other medical processes are projected to rise the acceptance of breast lesion localization methods.
Breast cancer is the most noticeable and invasive cancers, therefore, growing occurrence of it among women is anticipated to boost the market development.
As per Breast Cancer Organization, it was estimated that in 2018, around 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer would be detected. Increasing numeral of government and non-government compensation policies for breast cancer diagnostics, biopsy, and other related medical processes is expected to driver the acceptance of breast lesion localization approaches.
Increasing need for improved healthcare infrastructure and facilities and growing consciousness level about breast cancer screening are also estimated to drive the market development. Such as, national breast cancer screening program in Australia named the Breast Screen Australia that delivers free mammogram test services every 2 years for women aged between fifty and seventy four. Emerging regions, for instance, China and India, are also increasing consciousness about early analysis.
Market By Type
Market By Geography
North America captures the largest regional market and captured for 36.0% of the global market in 2018. The occurrence of well-established healthcare infrastructure and key producers in U.S. is anticipated to increase the regional development. Technological progressions paired with high economic growth in this region are also likely to boost the market.
Also, numerous activities by government and private firms to surge the consciousness is anticipated to spur the region’s growth. Such as, Wacoal America, Inc. planned a fund-raising activity, “Fit for the Cure”. The main objective was to contribute the treasuries to Susan G. Komen Breast Cancer Foundation and concurrently spread breast cancer consciousness in U.S.
Asia Pacific is anticipated to register the fastest CAGR of 16.3% during the forecast period due to high-unmet clinical needs, increasing disposable income level and patient awareness about early diagnosis. Also, speedily emerging healthcare infrastructure and growing need for breast conserving surgery are expected to provide potential development platform for this region. The industry is also driven by parameters, for instance, growing medical tourism in developing nations of APAC.
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the breast lesion localization methodsmarket are C.P. Medical, SOMATEX Medical Technologies GmbH, C.R. Bard, Argon Medical Devices, Inc., Inc., Cook Medical, Cianna Medical, and others.
According to Acumen Research and Consulting, the breast lesion localization methods market size is anticipated to be worth around US$ 2.3 billion in 2026.
The breast lesion localization methods market is anticipated to grow over 14% CAGR during the forecast period 2019 to 2026.
North America captures the largest regional market and captured for 36.0% of the global market in 2018.
Asia Pacific is anticipated to register the fastest CAGR of 16.3% during the forecast period.
The major players operating in the breast lesion localization methods market are C.P. Medical, SOMATEX Medical Technologies GmbH, C.R. Bard, Argon Medical Devices, Inc., Inc., Cook Medical, Cianna Medical, and others.
The types of breast lesion localization methods market are wire guided, radioisotope, magnetic tracer and others.
The breast lesion localization methods market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).